PCC Rokita S.A. (PCR.WA)
Brzeg Dolny, PL
PCC Rokita SA operates as a prominent producer and global supplier of chemical products, with operations extending across Poland and international markets. The company's diverse portfolio encompasses essential chemical categories such as chloralkali, polyurethanes, and a wide range of specialty products. Its core offerings further include key raw materials and intermediates, surfactants, various polyols, naphthalene, and phosphorus derivatives. PCC Rokita's extensive chemical solutions cater to a vast array of industrial applications and sectors, including adhesives, agrochemicals, building & construction, chemical reagents, detergents, fire prevention, the food & fuel industry, furniture manufacturing, industrial cleaning, lubricants & metalworking fluids, base oils, metallurgy, mining & drilling, oilfield operations, packaging, paints & coatings, personal care, pharmaceuticals, plastics, power generation, printing ink, pulp & paper, refrigeration & household appliances, sports & recreation, tanning & textile, transportation, vehicle cleaning & care, and water & wastewater treatment. Headquartered in Brzeg Dolny, Poland, PCC Rokita SA is an affiliate of the PCC SE group.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.43% | -0.86% | +3.59% | -1.00% | +3.74% | +7.28% | -4.02% | -34.25% | -5.07% | +16.08% | +43,212.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-7.5% Q1'26: -15.0% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-57.1% Q1'26: -292.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.1% Q1'26: +1.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+1.9% Q1'26: +0.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.8% Q1'26: +0.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.1% Q1'26: +2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.89× Q1'26: 3.46× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.05B
est: 1.05B (0.0%)
|
1.11B
est: 1.12B (-1.3%)
|
1.29B
est: 1.08B (+18.9%)
|
1.49B
est: 1.49B (+0.1%)
|
1.49B
est: 1.48B (+0.8%)
|
1.48B
est: 1.43B (+2.9%)
|
2.20B
est: 2.12B (+3.9%)
|
3.14B
est: 2.39B (+31.3%)
|
2.39B
est: 2.05B (+16.6%)
|
1.95B
est: 1.97B (-1.3%)
|
1.80B
est: 1.87B (-3.5%)
|
1.98B
1.91B – 2.05B
+6.1% YoY
|
2.06B
2.03B – 2.10B
+4.2% YoY
|
2.08B
2.01B – 2.14B
+0.6% YoY
|
2.17B
2.13B – 2.21B
+4.8% YoY
|
2.06B
2.03B – 2.10B
-5.1% YoY
|
| EBITDA |
153.49M
est: 262.18M (-41.5%)
|
248.89M
est: 280.42M (-11.2%)
|
268.37M
est: 270.28M (-0.7%)
|
338.98M
est: 371.99M (-8.9%)
|
263.61M
est: 369.81M (-28.7%)
|
325.12M
est: 358.49M (-9.3%)
|
652.17M
est: 529.76M (+23.1%)
|
1.02B
est: 598.23M (+70.4%)
|
519.07M
est: 464.34M (+11.8%)
|
372.74M
est: 447.54M (-16.7%)
|
188.36M
est: 423.10M (-55.5%)
|
448.91M
432.21M – 465.61M
+6.1% YoY
|
467.90M
459.42M – 476.39M
+4.2% YoY
|
470.50M
455.55M – 485.46M
+0.6% YoY
|
493.01M
484.07M – 501.95M
+4.8% YoY
|
467.81M
459.33M – 476.29M
-5.1% YoY
|
| EBIT |
101.73M
est: 178.05M (-42.9%)
|
236.46M
est: 190.44M (+24.2%)
|
198.06M
est: 183.55M (+7.9%)
|
252.20M
est: 252.62M (-0.2%)
|
163.13M
est: 251.14M (-35.0%)
|
177.79M
est: 243.45M (-27.0%)
|
483.54M
est: 359.76M (+34.4%)
|
832.80M
est: 406.26M (+105.0%)
|
344.90M
est: 305.92M (+12.7%)
|
193.83M
est: 294.85M (-34.3%)
|
34.02M
est: 278.75M (-87.8%)
|
295.75M
284.75M – 306.75M
+6.1% YoY
|
308.27M
302.68M – 313.85M
+4.2% YoY
|
309.98M
300.12M – 319.83M
+0.6% YoY
|
324.81M
318.92M – 330.70M
+4.8% YoY
|
308.21M
302.62M – 313.79M
-5.1% YoY
|
| Net Income |
84.75M
|
202.72M
est: 187.02M (+8.4%)
|
182.35M
est: 211.04M (-13.6%)
|
226.77M
est: 224.04M (+1.2%)
|
93.27M
est: 110.18M (-15.4%)
|
117.39M
est: 49.63M (+136.5%)
|
417.30M
est: 327.57M (+27.4%)
|
675.06M
est: 250.15M (+169.9%)
|
267.84M
est: 158.25M (+69.3%)
|
143.04M
est: 111.72M (+28.0%)
|
61.48M
est: 221.38M (-72.2%)
|
177.45M
173.27M – 181.64M
-19.8% YoY
|
201.77M
197.02M – 206.53M
+13.7% YoY
|
207.40M
186.41M – 228.40M
+2.8% YoY
|
198.79M
194.10M – 203.48M
-4.2% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
127.84M
est: 137.67M (-7.1%)
|
146.21M
est: 147.24M (-0.7%)
|
167.43M
est: 141.92M (+18.0%)
|
191.79M
est: 195.33M (-1.8%)
|
203.56M
est: 194.18M (+4.8%)
|
215.54M
est: 188.23M (+14.5%)
|
272.28M
est: 278.17M (-2.1%)
|
364.47M
est: 314.12M (+16.0%)
|
297.91M
est: 269.57M (+10.5%)
|
283.75M
est: 259.82M (+9.2%)
|
266.89M
est: 245.63M (+8.7%)
|
260.61M
250.92M – 270.31M
+6.1% YoY
|
271.64M
266.71M – 276.56M
+4.2% YoY
|
273.15M
264.47M – 281.83M
+0.6% YoY
|
286.22M
281.03M – 291.40M
+4.8% YoY
|
271.59M
266.66M – 276.51M
-5.1% YoY
|
| EPS |
4.27
|
10.21
est: 9.42 (+8.4%)
|
9.19
est: 10.63 (-13.5%)
|
11.42
est: 11.29 (+1.2%)
|
4.70
est: 5.55 (-15.3%)
|
5.91
est: 2.50 (+136.4%)
|
21.02
est: 16.50 (+27.4%)
|
34.00
est: 12.60 (+169.8%)
|
13.49
est: 7.97 (+69.2%)
|
7.21
est: 5.62 (+28.3%)
|
3.09
est: 12.68 (-75.6%)
|
8.93
8.72 – 9.14
-29.6% YoY
|
10.15
9.91 – 10.39
+13.7% YoY
|
10.43
9.38 – 11.49
+2.8% YoY
|
10.00
9.76 – 10.24
-4.2% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 51.1K | 0.39% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 10.4K | 0.46% |
| 3 | State Street SPDR Portfolio Europe ETF SPEU | 0.00% | 2.1K | 0.07% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 16.8K | 0.28% |
| 5 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 202.23 | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wieslaw Klimkowski | President of the Management & General Director | 8M | male |
| Adam Jarosz | Vice President of the Management Board | 3M | male |
| Robert Pabich | Secretary of the Supervisory Board & Independent Member of Supervisory Board | 258.0K | male |
| Beata Dobecka | Chief Accountant, Director of the Accounting Office CWB & Member of Management Board | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PCR.WA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
